Published in Urology on October 01, 2001
Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population. J Occup Environ Med (2015) 1.66
Association between smoking status, and free, total and percent free prostate specific antigen. J Urol (2012) 0.84
The effects of cigarette smoking on prostate-specific antigen in two different age groups. Can Urol Assoc J (2013) 0.77
Serial Percent Free Prostate Specific Antigen in Combination with Prostate Specific Antigen for Population Based Early Detection of Prostate Cancer. J Urol (2016) 0.76
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1). Asian J Androl (2015) 0.75
Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA (1998) 12.60
Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med (2001) 11.73
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med (1992) 7.16
Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med (1991) 6.94
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med (1998) 6.84
Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N Engl J Med (1989) 6.22
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med (1999) 6.21
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials (2000) 6.17
Prostate cancer screening: what we know and what we need to know. Ann Intern Med (1993) 5.84
Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials (2000) 5.37
The role of increasing detection in the rising incidence of prostate cancer. JAMA (1995) 3.79
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 3.40
Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst (1999) 3.35
Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol (2007) 3.24
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Quality of life in advanced prostate cancer: results of a randomized therapeutic trial. J Natl Cancer Inst (1998) 3.08
A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1992) 2.90
Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst (1995) 2.83
Lung cancer among workers in chromium chemical production. Am J Ind Med (2000) 2.55
Trends in biomarker research for cancer detection. Lancet Oncol (2001) 2.46
Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst (1997) 2.12
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med (1991) 2.07
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics (1992) 2.02
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
Mycosis fungoides. Survival, prognostic features, response to therapy, and autopsy findings. Medicine (Baltimore) (1972) 1.91
Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care (1998) 1.88
Lung cancer and the debrisoquine metabolic phenotype. J Natl Cancer Inst (1990) 1.86
Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. Am J Med (1982) 1.84
The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer (2000) 1.81
A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause? JAMA (1987) 1.75
Characterising the castration-resistant prostate cancer population: a systematic review. Int J Clin Pract (2011) 1.75
Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1994) 1.73
Hypoxic pulmonary vasoconstriction does not contribute to pulmonary blood flow heterogeneity in normoxia in normal supine humans. J Appl Physiol (1985) (2008) 1.71
Study design in the evaluation of breast cancer imaging technologies. Acad Radiol (2000) 1.71
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol (1997) 1.70
Surrogates' predictions of seriously ill patients' resuscitation preferences. Arch Fam Med (1995) 1.70
Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute. J Urol (1994) 1.69
Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology (1995) 1.69
Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med (1996) 1.69
Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med (1987) 1.68
Rotavirus as a cause of diarrheal morbidity and mortality in the United States. J Infect Dis (1988) 1.65
A cohort study of cancer among benzene-exposed workers in China: overall results. Am J Ind Med (1996) 1.63
Demographic characteristics of cancer of the pancreas: mortality, incidence, and survival. Cancer (1981) 1.58
Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg (1997) 1.56
Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res (1997) 1.54
Viral gastroenteritis aboard a cruise ship. Lancet (1989) 1.53
Occupational physical activity, socioeconomic status, and risks of 15 cancer sites in Turkey. Cancer Causes Control (1993) 1.51
Adenocarcinoma of the esophagus and esophagogastric junction in white men in the United States: alcohol, tobacco, and socioeconomic factors. Cancer Causes Control (1994) 1.50
Occupational exposure to chlorinated aliphatic hydrocarbons and risk of astrocytic brain cancer. Am J Ind Med (1994) 1.48
Cancer of the pancreas. Available epidemiologic information and its implications. Cancer (1973) 1.47
Double-blind, randomized, controlled trial of papaverine-containing infusions to prevent failure of arterial catheters in pediatric patients. Crit Care Med (1993) 1.46
Correlation of testicular color Doppler ultrasonography, physical examination and venography in the detection of left varicoceles in men with infertility. J Urol (1991) 1.46
Proposed substages for metastatic prostate cancer. Urology (1997) 1.45
Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst (1991) 1.42
A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology (1999) 1.41
Good for women, good for men, bad for people: Simpson's paradox and the importance of sex-specific analysis in observational studies. J Womens Health Gend Based Med (2001) 1.41
Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype. Cancer Res (1989) 1.41
Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst (1994) 1.40
Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy. N Engl J Med (1972) 1.40
An EPR dosimetry method for rapid scanning of children following a radiation accident using deciduous teeth. Health Phys (1999) 1.39
The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer. BJU Int (2003) 1.39
Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev (2001) 1.39
Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol (1999) 1.39
The "nutcracker" phenomenon: an unusual cause for renal varicosities with hematuria. J Urol (1980) 1.38
Biochemical response to testicular androgen ablation among patients with prostate cancer for whom flutamide and/or finasteride therapy failed. Urology (1998) 1.38
A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. J Clin Oncol (1991) 1.38
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Urology (1995) 1.38
Persistent pulmonary hypertension of the newborn infant. J Pediatr (1976) 1.37
Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires. Am J Epidemiol (2001) 1.35
Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res (1987) 1.34
Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis (2008) 1.33
A new microcellular cytotoxicity test based on calcein AM release. Hum Immunol (1993) 1.32
Diarrheal deaths in American children. Are they preventable? JAMA (1988) 1.31
Biochemical characterization of the amphotropic group of murine leukemia viruses. J Virol (1978) 1.31
Wood-related occupations, wood dust exposure, and sinonasal cancer. Am J Epidemiol (1986) 1.30
Cytogenetic effects of formaldehyde exposure in students of mortuary science. Cancer Epidemiol Biomarkers Prev (1993) 1.29
Quantification of regional pulmonary blood flow using ASL-FAIRER. Magn Reson Med (2006) 1.29
Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res (1998) 1.28
Morphologic analysis of the pulmonary vascular bed in congenital left-sided diaphragmatic hernia. J Pediatr (1978) 1.28
Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors. J Pediatr (1978) 1.28
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27